Literature DB >> 3377745

Early changes in collateral blood flow to ischemic myocardium and their influence on bimodal vulnerability during the first 30 min of acute coronary artery occlusion in dogs.

S von Mutius1, M Neumann, W Meesmann.   

Abstract

Coronary collateral blood flow and its changes during the first 30 min of acute coronary artery occlusion were studied in 34 anesthetized dogs to clarify its influence on the vulnerability of the heart in this first arrhythmic phase. Collateral flow was determined with 9-micron tracer microspheres (TM) injected at 1, 10 and 30 min after acute proximal occlusion of the left circumflex (LCX, n = 30) or left anterior descending (LAD, n = 4) coronary artery. The post-mortem selective retrograde coronary angiography was used to evaluate the functional extent of preexisting coronary collaterals. After acute LCX occlusions collateral flow increased significantly (p less than 0.05) from 17.8 +/- 2.7 ml.(min.100 g)-1 (mean +/- SE; n = 13) at 1 min to 29.3 +/- 5.1 ml . (min . 100 g)-1 at 30 min of occlusion in animals with well-formed preexisting coronary collaterals (group 1), whereas it was very low (4.7 +/- 0.6 ml . (min . 100 g)-1; n = 13) and changed only slightly in dogs with poor collaterals (group 2). Most of these animals died by ventricular fibrillation (VF) before a second measurement could be carried out. In four dogs with poor collaterals but an unusually small LCX area (group 3), flow remained almost constant (11.0 +/- 4.7 versus 11.0 +/- 4.4 ml . (min . 100 g)-1) during this period. Similar results were obtained in animals with acute LAD occlusion (group 4). Ventricular extrasystoles (VES) mainly developed in animals with poor collaterals and respective low and almost unchanging collateral flow (group 2,3,4) while none or only a few VES occurred in dogs in which flow initially was clearly higher and increased significantly (group 1). The animals of group 1, 3 and 4 all survived the first arrhythmic phase, whereas all the animals of group 2 died by VF, either in the arrhythmic subphase Ia (n = 7) or Ib (n = 6). The results of the present study show that only the initial magnitude of flow is decisive for the development of VES and VF during the first arrhythmic phase, whereas the subsequent increase in flow is of no importance to the bimodal vulnerability in the first arrhythmic phase (subphases Ia and Ib). The in vivo measured critical minimal collateral flow of about 5 ml . (min . 100 g)-1 corresponds well with the survival limit (border between collateral state III and IV) previously determined by post-mortem retrograde coronary angiography.

Entities:  

Mesh:

Year:  1988        PMID: 3377745     DOI: 10.1007/bf01907109

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  30 in total

1.  Some sources of error in measuring regional blood flow with radioactive microspheres.

Authors:  G D Buckberg; J C Luck; D B Payne; J I Hoffman; J P Archie; D E Fixler
Journal:  J Appl Physiol       Date:  1971-10       Impact factor: 3.531

2.  [Survival rate after acute experimental coronary occlusion as related to the spontaneous collateral vessels in hearts].

Authors:  W Meesmann; F W Schulz; G Schley; P Adolphsen
Journal:  Z Gesamte Exp Med       Date:  1970

Review 3.  The "border zone" in evolving myocardial infarction: controversy or confusion?

Authors:  D J Hearse; D M Yellon
Journal:  Am J Cardiol       Date:  1981-06       Impact factor: 2.778

4.  Apparent improvement in canine collateral myocardial blood flow during vasodilation depends on criteria used to identify ischemic myocardium.

Authors:  R E Patterson; E S Kirk
Journal:  Circ Res       Date:  1980-07       Impact factor: 17.367

5.  The interruption of collateral blood flow to the ischemic canine myocardium by embolization of a coronary artery with latex: effects on conduction delay and ventricular arrhythmias.

Authors:  D E Euler; C E Prood; J F Spear; E N Moore
Journal:  Circ Res       Date:  1981-07       Impact factor: 17.367

6.  Effects of time on volume and distribution of coronary collateral flow.

Authors:  M L Marcus; R E Kerber; J Ehrhardt; F M Abboud
Journal:  Am J Physiol       Date:  1976-02

7.  Exerimental coronary artery occlusion. III. The determinants of collateral blood flow in acute coronary occlusion.

Authors:  W Schaper
Journal:  Basic Res Cardiol       Date:  1978 Nov-Dec       Impact factor: 17.165

8.  Functional role of collateral flow in the ischaemic dog heart.

Authors:  J R Koke; N Bittar
Journal:  Cardiovasc Res       Date:  1978-05       Impact factor: 10.787

9.  Experimental coronary artery occlusion. I. Measurement of infarct size.

Authors:  W Schaper; H Frenzel; W Hort
Journal:  Basic Res Cardiol       Date:  1979 Jan-Feb       Impact factor: 17.165

10.  Regional redistribution of myocardial blood flow after coronary occlusion and reperfusion in the conscious dog.

Authors:  F C White; M Sanders; C M Bloor
Journal:  Am J Cardiol       Date:  1978-08       Impact factor: 2.778

View more
  4 in total

1.  Innate collateral segments are predominantly present in the subendocardium without preferential connectivity within the left ventricular wall.

Authors:  Pepijn van Horssen; Maria Siebes; Jos A E Spaan; Imo E Hoefer; Jeroen P H M van den Wijngaard
Journal:  J Physiol       Date:  2013-12-23       Impact factor: 5.182

2.  Three-dimensional analysis of regional mechanical function, blood flow and electrophysiological parameters during early myocardial ischemia in dogs.

Authors:  P Kowallik; D Baumgart; A Skyschally; T Ehring; G Heusch
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

3.  Reduced neuronal noradrenaline overflow in the ischaemic rat heart: importance of the severity of coronary flow reduction.

Authors:  X J Du; R A Riemersma
Journal:  Basic Res Cardiol       Date:  1991 Jan-Feb       Impact factor: 17.165

4.  Alterations of plasma nitric oxide, vascular endothelial growth factor, and soluble form of its receptor (sFlt-1) after resistance exercise: An experimental study.

Authors:  Parivash Shekarchizadeh Esfahanni; Karimian Jahangir; Majid Khazaei
Journal:  Adv Biomed Res       Date:  2014-07-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.